EUR 0.22
(-4.48%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - EUR | 0.0% |
2022 | - EUR | 0.0% |
2021 | - EUR | 0.0% |
2020 | - EUR | 0.0% |
2019 | - EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | - EUR | 0.0% |
2023 Q4 | - EUR | 0.0% |
2023 Q2 | - EUR | -100.0% |
2023 Q1 | 991 Thousand EUR | 0.0% |
2022 Q4 | - EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
European Medical Solutions | 14.35 Million EUR | 100.0% |
FERMENTALG | 6.8 Million EUR | 100.0% |
argenx SE | 281.12 Million EUR | 100.0% |
BioSenic S.A. | - EUR | NaN% |
Celyad Oncology SA | 1.26 Million EUR | 100.0% |
Hyloris Pharmaceuticals SA | 1.00 EUR | 100.0% |
Onward Medical N.V. | 936 Thousand EUR | 100.0% |
Oxurion NV | 128 Thousand EUR | 100.0% |
PHAXIAM Therapeutics S.A. | 671 Thousand EUR | 100.0% |
Financière de Tubize SA | - EUR | NaN% |
UCB SA | 1.03 Billion EUR | 100.0% |